Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Egile Nagusiak: Tangui Barré (Egilea), Fabrice Carrat (Egilea), Clémence Ramier (Egilea), Hélène Fontaine (Egilea), Vincent Di Beo (Egilea), Morgane Bureau (Egilea), Céline Dorival (Egilea), Dominique Larrey (Egilea), Elisabeth Delarocque-Astagneau (Egilea), Philippe Mathurin (Egilea), Fabienne Marcellin (Egilea), Ventzislava Petrov-Sanchez (Egilea), Carole Cagnot (Egilea), Patrizia Carrieri (Egilea), Stanislas Pol (Egilea), Camelia Protopopescu (Egilea), the ANRS/AFEF Hepather study group (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...